Recently there was much confusion about blood thinners in India as well, with the ICMR ultimately saying there was no need to worry, and it was safe to take the vaccine for all (after consulting a doctor first).
Why has this become an issue in the EU? Should India, which manufactures the same vaccine, be worried?
Fortis cardiologist Dr Pramod Kumar clarifies, “The worries over blood thinners in India and Europe are very different. Here, no one should worry and all should take the vaccine if it’s available to you.”
So what is the problem? “In Europe, the vaccine was stopped as a precautionary measure. The blood became thick and a 50-year-old died post taking the jab although a link was not found. In fact, the regulatory body said there was no scientific link between the two incidents.”
Italy’s medicines body said its decision was “precautionary”, adding that no link had been established between the vaccine and subsequent “serious adverse events”.
So far, Denmark, Norway and…
